SCHEMBL7666245

SCHEMBL7666245

Fc1cccnc1Sc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.45
ATM Q13315 1/20 0.44
ALDH1A1 P00352 8/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
MAPT P10636 2/20 0.38
PPP1CA P62136 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8457892 0.76 SMN1; SMN2 (0.49) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL6136756 0.76 SMN1; SMN2 (0.49) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL15924869 0.76 SMN1; SMN2 (0.45) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL10726183 0.76 ALDH1A1 (0.71) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL8131505 0.76 SMN1; SMN2 (0.46) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL13990584 0.73 SMN1; SMN2 (0.54) SMN1; SMN2ATMALDH1A1HPGDKDM4E
SCHEMBL5087696 0.73 SMN1; SMN2 (0.61) SMN1; SMN2ATMALDH1A1CYP2C9GAA
SCHEMBL24645057 0.72
SCHEMBL31439210 0.72
SCHEMBL17200760 0.72 ALDH1A1 (0.43) SMN1; SMN2ATMALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed